Efficacy and Safety of Saxagliptin in Combination With Insulin in Elderly Patients With Type 2 Diabetes

被引：0
|
作者：
Charbonnel, Bernard
Barnett, Anthony H.
Monyak, John
Minervini, Gianmaria
Iqbal, Nayyar
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1048-P
引用
收藏
页码：A269 / A269
页数：1
相关论文
共 50 条
  • [21] Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
    Jain, Rajeev
    ADVANCES IN THERAPY, 2015, 32 (11) : 1065 - 1084
  • [22] Utility of Saxagliptin in the Treatment of Type 2 Diabetes: Review of Efficacy and Safety
    Rajeev Jain
    Advances in Therapy, 2015, 32 : 1065 - 1084
  • [23] Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis
    Men, Peng
    Li, Xiao-tong
    Tang, Hui-lin
    Zhai, Suo-di
    PLOS ONE, 2018, 13 (05):
  • [24] Efficacy and safety of saxagliptin (SAXA) in patients with type 2 diabetes stratified by cardiovascular risk factors
    Allen, E.
    Slater, J.
    Bryzinski, B.
    Donovan, M.
    Cook, W.
    DIABETOLOGIA, 2012, 55 : S346 - S347
  • [25] Rosiglitazone: safety and efficacy in combination with insulin in poorly controlled type 2 diabetes mellitus patients treated with insulin alone
    Garg, Ranjna
    Gopal, Jayanthi
    Jones, Geraint Rhys
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (01) : 1 - 6
  • [26] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus
    Tago, Motoko
    Oyama, Jun-ichi
    Sakamoto, Yoshiko
    Shiraki, Aya
    Uchida, Fumi
    Chihara, Atsuko
    Ikeda, Hideo
    Kuroki, Shigetaka
    Gondo, Shigeki
    Iwamoto, Taketo
    Uchida, Yasufumi
    Node, Koichi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (04) : 631 - 639
  • [27] Safety and Efficacy of Linagliptin and Basal Insulin Combination Therapy in Elderly Patients (age ≥70 years) with Type 2 Diabetes (T2D)
    Woerle, H. J.
    Neubacher, D.
    Patel, S.
    von Eynatten, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S31 - S32
  • [28] Safety and efficacy of linagliptin plus basal insulin combination therapy in a vulnerable population of elderly patients (age ≥70 years) with type 2 diabetes
    Woerle, H. -J.
    Neubacher, D.
    Patel, S.
    von Eynatten, M.
    DIABETOLOGIA, 2012, 55 : S350 - S350
  • [29] EFFICACY AND SAFETY OF SAXAGLIPTIN, DIPEPTIDYL PEPTIDASE-4 INHIBITOR, IN HEMODIALYSIS PATIENTS WITH TYPE 2 DIABETES
    Abe, M.
    Otsuki, T.
    Maruyama, N.
    Oikawa, O.
    Okada, K.
    NEPHROLOGY, 2016, 21 : 65 - 65
  • [30] Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitus
    Hollander, Priscilla L.
    Li, Jia
    Frederich, Robert
    Allen, Elsie
    Chen, Roland
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (02): : 125 - 135
12345